• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因干细胞移植后慢性特发性骨髓纤维化患者骨髓变化的动态研究

Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.

作者信息

Thiele J, Kvasnicka H M, Dietrich H, Stein G, Hann M, Kaminski A, Rathjen N, Metz K A, Beelen D W, Ditschkowski M, Zander A, Kroeger N

机构信息

Institute of Pathology, University of Cologne, Joseph-Stelzmannstrasse 9, D-50924 Cologne, Germany.

出版信息

Histol Histopathol. 2005 Jul;20(3):879-89. doi: 10.14670/HH-20.879.

DOI:10.14670/HH-20.879
PMID:15944939
Abstract

Scant knowledge exists about the dynamics of fibro-osteosclerotic bone marrow (BM) lesions and regeneration of hematopoiesis following allogeneic peripheral stem cell transplantation (SCT) in chronic idiopathic myelofibrosis. Therefore, an immunohistochemical and morphometric study was performed on BM biopsies in 20 patients before and at standardized intervals (days 30 through 384) following SCT. In responding patients, a total regression of the pretransplant increased fibrosis was completed in the posttransplant period after about six months, while the extent of osteosclerosis did not change significantly during observation time. The quantity of CD61+ megakaryocytes including precursors was strikingly variable after SCT and, by using planimetric methods, atypical microforms exhibiting a dysplastic aspect could be demonstrated. These anomalies may be responsible for posttransplant thrombocytopenia. CD34+ progenitor cells were increased before transplantation, however, their number declined rapidly to normal values in responding patients. Nucleated erythroid precursors revealed a decreased amount before and after SCT accounting for anemia. Large clusters of this cell lineage indicated an initial hematopoietic reconstitution comparable with the expansion of the neutrophil granulopoiesis. Proliferative activity and apoptosis showed an increase until one year after SCT that implied a still regenerating hematopoiesis in keeping with an enhanced cell turnover.

摘要

关于慢性特发性骨髓纤维化患者接受异基因外周血干细胞移植(SCT)后纤维性骨硬化性骨髓(BM)病变的动态变化以及造血功能的再生,目前所知甚少。因此,我们对20例患者在SCT前及SCT后标准化时间间隔(第30天至384天)的骨髓活检组织进行了免疫组织化学和形态计量学研究。在有反应的患者中,移植前增加的纤维化在移植后约六个月的时间内完全消退,而骨硬化程度在观察期内未发生显著变化。SCT后,包括前体细胞在内的CD61+巨核细胞数量变化显著,通过平面测量法可发现表现为发育异常的非典型微形态。这些异常可能是移植后血小板减少的原因。移植前CD34+祖细胞数量增加,但在有反应的患者中其数量迅速降至正常水平。有核红细胞前体细胞在SCT前后数量均减少,这导致了贫血。该细胞系的大簇集表明初始造血重建与中性粒细胞生成的增加相当。增殖活性和凋亡在SCT后一年之内均有所增加,这意味着造血功能仍在再生,与细胞更新增强一致。

相似文献

1
Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.异基因干细胞移植后慢性特发性骨髓纤维化患者骨髓变化的动态研究
Histol Histopathol. 2005 Jul;20(3):879-89. doi: 10.14670/HH-20.879.
2
Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.异基因骨髓移植后慢性髓性白血病的巨核细胞生成与骨髓纤维化:127例患者的免疫组织化学研究
Mod Pathol. 2001 Feb;14(2):129-38. doi: 10.1038/modpathol.3880269.
3
Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation.
Histol Histopathol. 2007 Apr;22(4):365-72. doi: 10.14670/HH-22.365.
4
[Complete regression of bone marrow fibrosis following allogeneic peripheral blood stem cell transplantation in a patient with idiopathic myelofibrosis].[异基因外周血干细胞移植后特发性骨髓纤维化患者骨髓纤维化完全消退]
Cesk Patol. 2004 Oct;40(4):167-71.
5
Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis.
Am J Clin Pathol. 2005 Jun;123(6):833-9. doi: 10.1309/7A5J-U9KJ-K89V-QPH9.
6
Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.骨髓植入:慢性粒细胞白血病患者异基因移植后造血重建的组织病理学
Histol Histopathol. 2001 Jan;16(1):213-26. doi: 10.14670/HH-16.213.
7
Dynamics of CD34+ progenitor cells following allogeneic bone marrow transplantation in Ph1+CML--an immunohistochemical study on 113 patients with sequential trephine biopsies.
J Hematother Stem Cell Res. 2002 Jun;11(3):565-74. doi: 10.1089/15258160260091022.
8
Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.慢性髓性白血病中CD34+祖细胞的治疗相关变化:对连续环钻活检的形态计量学研究
J Hematother Stem Cell Res. 2001 Dec;10(6):827-36. doi: 10.1089/152581601317210926.
9
Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.异基因骨髓移植后慢性髓性白血病造血重建中骨髓纤维化的相关性及动态变化——160例患者的单中心经验
Bone Marrow Transplant. 2000 Aug;26(3):275-81. doi: 10.1038/sj.bmt.1702505.
10
Regression of myelofibrosis and osteosclerosis following hematopoietic cell transplantation assessed by magnetic resonance imaging and histologic grading.通过磁共振成像和组织学分级评估造血细胞移植后骨髓纤维化和骨硬化的消退情况。
Biol Blood Marrow Transplant. 2006 Dec;12(12):1285-94. doi: 10.1016/j.bbmt.2006.07.008.

引用本文的文献

1
Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis.通过异基因造血干细胞移植重建骨髓纤维化中的骨骼稳态。
Nat Commun. 2025 Jan 20;16(1):741. doi: 10.1038/s41467-025-55915-w.
2
TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with (-) Classical Myeloproliferative Neoplasm.TLR2 失调可能在 (-) 经典骨髓增殖性肿瘤患者的炎症反应和血栓形成中起重要作用。
Mediators Inflamm. 2024 Aug 9;2024:1827127. doi: 10.1155/2024/1827127. eCollection 2024.
3
PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in (-) Myeloproliferative Neoplasm: A Review.
PD-1/PD-L1、髓系来源抑制细胞途径与检查点抑制剂治疗骨髓增殖性肿瘤:综述
Int J Mol Sci. 2022 May 23;23(10):5837. doi: 10.3390/ijms23105837.
4
Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study.异基因干细胞移植联合间充质干细胞输注治疗原发性骨髓纤维化:一项多中心回顾性研究
Front Oncol. 2022 Jan 24;11:792142. doi: 10.3389/fonc.2021.792142. eCollection 2021.
5
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party.异基因造血细胞移植治疗骨髓纤维化:EBMT 慢性恶性肿瘤工作组关于移植物失败、移植物功能不良和复发的定义和管理策略建议:最佳实践推荐。
Leukemia. 2021 Sep;35(9):2445-2459. doi: 10.1038/s41375-021-01294-2. Epub 2021 May 26.
6
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT.既往使用鲁索利替尼治疗 JAK 抑制剂对骨髓纤维化患者异基因造血干细胞移植后结局的影响:来自 EBMT 的 CMWP 的研究。
Leukemia. 2021 Dec;35(12):3551-3560. doi: 10.1038/s41375-021-01276-4. Epub 2021 May 22.
7
[Fibrosis-driving cells in patients with primary myelofibrosis and myelodysplastic syndromes with myelofibrosis].[原发性骨髓纤维化和骨髓增生异常综合征伴骨髓纤维化患者中驱动纤维化的细胞]
Zhonghua Xue Ye Xue Za Zhi. 2020 Dec 14;41(12):1002-1007. doi: 10.3760/cma.j.issn.0253-2727.2020.12.006.
8
Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms.炎症因子在骨髓增殖性肿瘤疾病发病机制及干细胞移植中的作用
Cancers (Basel). 2020 Aug 12;12(8):2250. doi: 10.3390/cancers12082250.
9
Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to.芦可替尼为基础的联合治疗在骨髓纤维化中的应用:值得期待。
Ann Hematol. 2020 Jun;99(6):1161-1176. doi: 10.1007/s00277-020-04028-z. Epub 2020 Apr 24.
10
Allogeneic hematopoietic stem-cell transplantation for myelofibrosis.异基因造血干细胞移植治疗骨髓纤维化
Ther Adv Hematol. 2020 Feb 13;11:2040620720906002. doi: 10.1177/2040620720906002. eCollection 2020.